Online Inquiry

For Research Use Only. Not For Clinical Use.

Contact Us
  • Email:

Cholinergic Neuron Differentiation Service

Introduction Cholinergic Neuron Differentiation Service Workflow What We Can Offer Case Study FAQ
Inquiry Now

Introduction

Cholinergic neurons are vital for cognitive function, and their degeneration is a key feature of Alzheimer's disease and other dementias. Studies show that dopamine, Vitamin E, and BDNF promote cholinergic differentiation, while the IRE1α‑XBP1 pathway protects against ER stress. Creative Biolabs offers a Cholinergic Neuron Differentiation Service using optimized induction and 3D culture to generate high‑purity, mature neurons expressing ChAT and VAChT. These functionally validated cells support disease modeling, drug screening, and neuroregeneration research with high clinical translatability.

Discover How We Can Help - Request a Consultation

Cholinergic Neuron Differentiation Service

Cholinergic neurons are pivotal for memory, cognition, motor control, and autonomic function. Loss of cholinergic signaling is strongly linked to multiple neurodegenerative and neurological disorders.

Key Features

  • Derived from human iPSCs/ESCs under defined, xeno-free conditions
  • Uses dual SMAD inhibition and Wnt/Shh modulation for efficient specification
  • Generates region-specific cholinergic neurons (basal forebrain, spinal cord, brainstem)
  • High expression of key markers: ChAT, VAChT, MAP2, βIII‑tubulin

Service Content

  • Cholinergic neuron progenitor induction & expansion
  • Maturation into functional, neurotransmitter-releasing neurons
  • Quality validation: immunofluorescence, qPCR, flow cytometry
  • Optional: electrophysiology, calcium imaging, co-culture, disease modeling

Associated Diseases & Mechanisms

Disease Main Mechanism Related to Cholinergic Neurons Core Clinical Features
Alzheimer's Disease Degeneration of basal forebrain cholinergic neurons; reduced acetylcholine Memory loss, cognitive impairment
Parkinson's Disease Dementia Cholinergic deficits in the cortex and limbic system Dementia, cognitive decline
Amyotrophic Lateral Sclerosis (ALS) Loss of spinal cholinergic motor neurons Muscle weakness, paralysis
Myasthenia Gravis Autoantibodies against cholinergic receptors at the neuromuscular junction Muscle fatigue, weakness
Schizophrenia Cortical cholinergic hypofunction Attention and executive dysfunction

Applications

  • Disease modeling (AD, dementia, ALS, myasthenia gravis)
  • High‑throughput drug screening & neurotoxicity testing
  • Study of synaptic plasticity, memory circuits, and cholinergic transmission
  • 3D brain assembloid & cholinergic circuit models

Workflow

To initiate the service, clients typically provide Starting Materials such as:

  1. Target cell lines (e.g., patient-derived iPSCs or hAD-MSCs).
  2. Desired disease-specific genetic background information.
  3. Specific assay requirements (e.g., 2D monolayer vs. 3D Spheroid).

What We Can Offer

Creative Biolabs provides a robust, end-to-end platform for Cholinergic Neuron Differentiation, delivering high-fidelity cellular models that bridge the gap between basic research and clinical application. Our service offerings are characterized by:

Proprietary Triple-Action Induction

Utilization of a validated protocol combining Dopamine, Vitamin E, and BDNF to maximize ChAT-positive yields.

Scalable 3D Spheroid Production

Efficient transition from laboratory-scale 2D cultures to large-batch 3D spheroids for high-throughput screening (HTS).

Custom Genetic Engineering

Full capability to differentiate Cas9-engineered or patient-derived iPSCs harboring specific AD/PD mutations.

Resilience Engineering

Integration of ER-stress modulation techniques (sXBP1/CHOP balancing) to guarantee the survival of neurons in proteotoxic assays.

All-side Phenotypic Validation

Quality-by-Design (QbD) approach using RNA-Seq, High Content Screening (HCS), and advanced immunostaining.

Flexible Functional Assays

Real-time monitoring of neuronal activity through Multi-Electrode Array (MEA) or calcium imaging to confirm electrophysiological maturity.

Strict Quality Control (QC)

Every batch is assessed for purity, marker specificity (VAChT, SLC18A3), and metabolic health (ATP assays) to ensure experimental reproducibility.

Bespoke Project Design

Fully customizable differentiation timelines and validation parameters tailored to your specific therapeutic target or research goals.

Experience the Creative Biolabs Advantage - Get a Quote Today

Case Study

To verify the effect of dopamine and vitamin E on the differentiation of mesenchymal stem cells into cholinergic neurons, the study conducted immunocytochemical and Western blot experiments to detect the expression of neural and neuronal subtype markers. The results showed that compared with the untreated group and the conventional neural induction medium (CIM) group, the treatment with dopamine-vitamin E increased the expression of neural stem cell marker Nestin, mature neuron marker MAP2, and NeuN; and upregulated dopamine-related marker DAT, DBH, and cholinergic core marker CHAT, in a dose-dependent manner. This indicates that the combination of dopamine and vitamin E can effectively enhance the neural differentiation ability of MSCs and promote their directional differentiation into cholinergic neuron subtypes.

CHAT protein levels in non-induced MSCs cells, cells treated with conventional induction media (CIM), and in cells treated with CIM supplemented with 2 concentrations of dopamine (dop) and vitamin E (Vit E). (OA Literature) Fig.1 Detect the CHAT expression of cholinergic neuron cells differentiated from mesenchymal stem cells.1

Customer Reviews

FAQs

Q: Can you differentiate patient-specific iPSCs with known AD mutations?

A: Yes, we specialize in custom differentiation of various cell sources, including patient-derived iPSCs, ensuring that the genetic background is preserved while the cholinergic phenotype is optimized.

Q: How do your 3D spheroids compare to traditional 2D cultures?

A: Our 3D spheroids offer superior metabolic health and enhanced expression of mature markers like MAP2, providing a more predictive environment for drug efficacy studies.

Q: What is the purity level of the ChAT-positive neurons?

A: We consistently achieve high-purity yields, typically validated by immunostaining and RNA-Seq. Specific purity percentages can vary based on the starting cell line.

Q: Do you offer functional validation like patch-clamping?

A: We provide high-throughput functional validation via Microelectrode Array (MEA) and calcium imaging; specialized patch-clamping services are available upon request.

Q: How are the cells shipped to ensure viability?

A: We utilize specialized cold-chain logistics for live cultures or dry-ice shipping for cryopreserved cells, following rigorous protocols to maintain a >90% post-thaw viability rate.

Creative Biolabs offers a suite of services for Cholinergic Neuron Differentiation, ranging from initial lineage specification to advanced 3D disease modeling and functional validation. Our technology ensures that your neuroregeneration projects are built on a foundation of high-purity, resilient, and functionally active neurons.

Contact Our Team for More Information and to Discuss Your Project

Reference

  1. Khaswaneh, Ramada R., et al. "Combining dopamine and vitamin E enhances the differentiation to cholinergic neurons of mesenchymal stem cells." Journal of Neuropathology & Experimental Neurology 84.8 (2025): 680-691. Distributed under Open Access license CC BY 4.0, without modification. https://doi.org/10.1093/jnen/nlaf025.

For Research Use Only. Not For Clinical Use.

Inquiry Basket